Latest filing published 25 Nov 2024 for Aurinia Pharmaceuticals Inc..
Filing timeline
BuySaleInsider track record
David R.W. Jayne: trading record in brief
All filings by David R.W. Jayne on record concern Aurinia Pharmaceuticals Inc. The record holds 6 filings, for trades running from 18 May 2022 to 21 November 2024.
On the market, this insider has only sold: 2 sales, €117k in total. The rest of the record consists of 2 share grants and 2 option exercises. So far in 2024, the count stands at no purchases and 1 sale.
The record was last updated on 25 November 2024 with a share grant in Aurinia Pharmaceuticals Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to David R.W. Jayne
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 12,135 shares0Common SharesSEC:0001600620-24-000118:0
- 4,946 shares@ US$5.7417.2% of flowCommon StockSEC:0001600620-24-000074:0
- 8,733 shares@ US$11.2660.1% of flowCommon StockSEC:0001600620-23-000022:2
- 8,733 sharesCommon StockSEC:0001600620-23-000022:0
- 9,310 shares0Common StockSEC:0001600620-23-000022:1
- 10,000 shares@ US$3.6222.7% of flowCommon StockSEC:0001628280-22-018767:0
6 of 6 declarations
